Barrett Esophagus
145
25
36
61
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
22 trials with published results (15%)
Research Maturity
61 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.6%
11 terminated out of 145 trials
84.7%
-1.8% vs benchmark
1%
2 trials in Phase 3/4
36%
22 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (145)
Obeticholic Acid for Prevention in Barrett's Esophagus
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
A Study Comparing the Effectiveness of EndoRotor Versus Radiofrequency in Treating Barrett's Esophagus
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
Outcomes After Transoral Incisionless Fundoplication (TIF) Following Successful Endoscopic Ablation for Barrett's Esophagus
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
Pilot Study of Salivary Bile Acids and Pepsin as Predictive Biomarkers of Reflux Disease After Sleeve Gastrectomy
C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.
Longitudinal Oral Microbiome Sampling for BE
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
Impact of RFA on Esophageal Distensibility and Mucosal Impedance
Trans-Oral Sampling as an Alternative Surveillance of Barrett's Esophagus Pilot
Clinical Utility of WATS3D: A 5-Year Prospective Study